Go Beyond Testing: SARS-CoV-2 Antigen Rapid Test Kit

Company news

As a manufacturer and innovator, we Bioperfectus are always on the way to go beyond testing.


We today are pleased to announce that our SARS-CoV-2 antigen rapid test kit has been upgraded to meet higher market requirements:


  • Clinically approved sensitivity: 97.1%
  • Clinically approved specificity: 99.2%
  • Multiple packaging: 1T/2T/5T/10T/15T/20T/25T/50T
  • No drop in sensitivity in face of VOC1 Kent, UK, B1.1.7 and VOC2 South Africa, B.1.351
  • Able to detect asymptomatic cases
  • Optional positive control for quality assurance


For more information about our product, please send an inquiry email to info@bioperfectus.com, media cooperation & news release: marketing_global@bioperfectus.com.



Empowering Women's Health: Gynecologic Cancer Awareness Month

September is Gynecologic Cancer Awareness Month! Join us in raising awareness this month.


Academy Express | Human Papillomavirus (HPV) Infection and Its Impact on Male Infertility

HPV semen infection, regardless of HPV type and exact location of the virions, significantly impairs spermatozoa’s progressive motility, morphology, and immotile sperm rate.


World Sexual Health Day 2023: Empowering Sexual Well-being

Today serves as a reminder to prioritize sexual health and foster positive attitudes toward consent.